WHY TO ATTEND
Adverse Effects of Protein Aggregates
Limits of Predictive Experiments
Critical Process and Formulation Parameters
Occurrence of Particles in Drug Products
Meet the expert trainers
Dr. Robert E. Zoubek
Senior Consultant at Granzer Regulatory Consulting & Services
Dr. Zoubek is passionate biochemist with large experience in the mitigation of protein aggregation and degradation, and the effective design of formulation studies - an experience which he combines wi
Manager Pharma Technical Regulatory Affairs at Roche
Dr. Hans Rogl is Manager of Pharma Technical Regulatory Affairs, at Roche, Germany. He has worked in the biopharmaceutical industry with focus on downstream processing of therapeutic proteins since mo
Who should attend
Are you interested in the event?
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
One of our sales representatives will call you according to your preferences.
Thank you for your interest.
We appreciate your interest in this topic. The download should start automatically.
Your payment was successfull.
You should receive link to download your recording shortly.
Your friends have invites in their inbox.